La Jolla Pharmaceutical

Biopharma takeovers show quantity, if not quality

Second-quarter deal values plummeted as Covid-19 spread and the prices of target companies spiralled.

Tetraphase’s love quadrangle sees three bald men fight over a comb

May 11, 2020

Hepcidin becomes the Protagonist for a second biotech

July 03, 2019

Share price catalysts: June 2019

June 07, 2019

La Jolla gets new injection of life

January 08, 2019

JP Morgan 2019 day one roundup – happy days are here again

The takeovers of Loxo and Celgene put M&A back on the agenda, and positive clinical readouts from Sage and Axsome add to the celebratory mood.

February 28, 2017

La Jolla shocks the market with a positive study

October 14, 2016

Upcoming events – Acadia data in Alzheimer's and La Jolla's acute blood pressure project

June 10, 2015

Sage advice takes Marinus higher

May 11, 2015

La Jolla down to one clinical candidate

November 04, 2014

Galecto rewarded for its focus on a tangible target

Load More